Kazia Therapeutics Ltd
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +2.3% | +4,474.2% | +115.9% | -99.9% | -88.1% | +63,038.0% | +1,436.6% | -99.9% | -94.5% | +415,755.9% | -98.2% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +2.3% | +4,474.2% | +115.9% | -99.9% | -88.1% | +63,038.0% | +1,436.6% | -99.9% | -94.5% | +415,755.9% | -98.2% | |
| – | +139.7% | +66.7% | +12.6% | -12.2% | -33.7% | +46.6% | +53.2% | +38.7% | -22.8% | +11.7% | -57.8% | |
| – | -9.9% | +49.9% | +48.0% | -34.4% | -32.4% | -2.5% | +90.3% | -27.2% | +67.9% | +58.0% | -35.7% | |
| – | +43.6% | +61.5% | +25.7% | -25.3% | -30.2% | +28.6% | +63.5% | +17.9% | -5.1% | +27.5% | -53.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -90.4% | -100.0% | – | -100.0% | – | -89.0% | +2,024.2% | -100.0% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +50.7% | +92.7% | -107.2% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.